News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Waksal Harlan
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/02/2023 |
4
| Waksal Harlan (Executive Chair) has filed a Form 4 on Lyra Therapeutics, Inc.|
Txns:
| Granted 200,000 options
@ $2.85, valued at
$570k
|
|
| 06/21/2022 |
4
| Waksal Harlan (Executive Chair) has filed a Form 4 on Lyra Therapeutics, Inc.|
Txns:
| Granted 953,002 options
@ $5.09, valued at
$4.9M
|
|
| 04/13/2022 |
4
| Waksal Harlan (Executive Chair) has filed a Form 4 on Lyra Therapeutics, Inc.|
Txns:
| Bought 236,966 shares
@ $4.22, valued at
$1000k
|
|
| 02/18/2022 |
4
| Waksal Harlan (Executive Chair) has filed a Form 4 on Lyra Therapeutics, Inc.|
Txns:
| Granted 520,000 options
@ $4.21, valued at
$2.2M
|
|
| 02/18/2022 |
3
| Waksal Harlan (Executive Chair) has filed a Form 3 on Lyra Therapeutics, Inc. |
| 11/09/2021 |
4
| Waksal Harlan (President, CEO) has filed a Form 4 on Kadmon Holdings, Inc.|
Txns:
| Disposed/sold 177,945 shares
@ $9.5, valued at
$1.7M
Disposed/sold 655,000 rights
@ $3.64, valued at
$2.4M
Disposed/sold 982,500 options to buy
@ $4.06, valued at
$4M
Disposed/sold 1,350,000 options to buy
@ $4.15, valued at
$5.6M
Disposed/sold 2,000,000 options to buy
@ $3.96, valued at
$7.9M
Disposed/sold 750 options to buy
@ $6, valued at
$4.5k
|
|
| 05/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/10/2020 |
4
| Waksal Harlan (President, CEO) has filed a Form 4 on Kadmon Holdings, Inc.|
Txns:
| Granted 109,167 options to buy
@ $4.06, valued at
$443.2k
|
|
| 03/16/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/11/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/19/2019 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 11/19/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/24/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/10/2019 |
4
| Waksal Harlan (President, CEO) has filed a Form 4 on Kadmon Holdings, Inc.|
Txns:
| Granted 109,167 options to buy
@ $4.06, valued at
$443.2k
|
|
| 06/14/2019 |
4
| Waksal Harlan (President, CEO) has filed a Form 4 on Kadmon Holdings, Inc.|
Txns:
| Granted 109,167 options to buy
@ $4.06, valued at
$443.2k
|
|
| 04/05/2019 |
4
| Waksal Harlan (President, CEO) has filed a Form 4 on Kadmon Holdings, Inc.|
Txns:
| Granted 218,334 options to buy
@ $4.06, valued at
$886.4k
|
|
| 12/12/2017 |
4
| Waksal Harlan (President, CEO) has filed a Form 4 on Kadmon Holdings, Inc.|
Txns:
| Granted 655,000 rights
@ $3.64, valued at
$2.4M
|
|
| 08/10/2017 |
4
| Waksal Harlan (President, CEO) has filed a Form 4 on Kadmon Holdings, Inc.|
Txns:
| Bought 5,000 shares
@ $2.2665, valued at
$11.3k
|
|
| 08/08/2017 |
4
| Waksal Harlan (President, CEO) has filed a Form 4 on Kadmon Holdings, Inc.|
Txns:
| Bought 3,707 shares
@ $2.3379, valued at
$8.7k
|
|
| 11/16/2016 |
4
| Waksal Harlan (President, CEO) has filed a Form 4 on Kadmon Holdings, Inc. |
| 11/14/2016 |
4
| Waksal Harlan (President, CEO) has filed a Form 4 on Kadmon Holdings, Inc. |
| 07/26/2016 |
3
| Waksal Harlan (President, CEO) has filed a Form 3 on Kadmon Holdings, LLC |
| 11/23/2015 |
4
| Waksal Harlan (Director) has filed a Form 4 on Sevion Therapeutics, Inc.|
Txns:
| Granted 40,000 options to buy
@ $0.5, valued at
$20k
|
|
| 05/20/2015 |
4
| Waksal Harlan (Director) has filed a Form 4 on Sevion Therapeutics, Inc.|
Txns:
| Granted 11,340 options
@ $0.97, valued at
$11k
Granted 11,340 options
@ $0.97, valued at
$11k
|
|
| 02/23/2015 |
4
| Waksal Harlan (Director) has filed a Form 4 on Sevion Therapeutics, Inc.|
Txns:
| Granted 26,552 options
@ $0.54, valued at
$14.3k
|
|
| 11/20/2014 |
4
| Waksal Harlan (Director) has filed a Form 4 on Sevion Therapeutics, Inc.|
Txns:
| Granted 38,034 options to buy
@ $0.83, valued at
$31.6k
Granted 17,168 options to buy
@ $0.83, valued at
$14.2k
|
|
| 05/16/2014 |
4
| Waksal Harlan (Director) has filed a Form 4 on SENESCO TECHNOLOGIES INC|
Txns:
| Granted 21,932 options
@ $2.77, valued at
$60.8k
|
|
| 09/24/2013 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities [Amend] |
| 09/16/2013 |
4
| Waksal Harlan (Director) has filed a Form 4 on SENESCO TECHNOLOGIES INC|
Txns:
| Granted 530,000 options
@ $0.054, valued at
$28.6k
|
|
| 05/20/2013 |
4
| Waksal Harlan (Director) has filed a Form 4 on SENESCO TECHNOLOGIES INC|
Txns:
| Granted 273,256 options
@ $0.043, valued at
$11.8k
|
|
| 02/20/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/16/2012 |
4
| Waksal Harlan (Director) has filed a Form 4 on SENESCO TECHNOLOGIES INC|
Txns:
| Granted 420,000 options
@ $0.165, valued at
$69.3k
Granted 165,152 options
@ $0.165, valued at
$27.3k
|
|
|
|
|